JENNIFER ADAMS: Open Payments
NPI 1366914434 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 27 payments from 14 companies in 2025. Trend: 2023 $626 · 2024 $55 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 1 | $100 |
| Novo Nordisk Inc | 4 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Lilly USA, LLC | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Antares Pharma, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: TRITON CANISTER SYSTEM, REXULTI, Wegovy, Kerendia, XYOSTED, GEMTESA, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
